We are live on ! Find out more
TAM

Tiverton Asset Management Portfolio holdings

AUM $2.88B
1-Year Est. Return 5.6%
This Fund
S&P 500
This Quarter Est. Return
+4.6%
1 Year Est. Return
+5.6%
3 Year Est. Return
+61.83%
5 Year Est. Return
+105.31%
10 Year Est. Return
AUM
$2.8B
AUM Growth
+$499M
Cap. Flow
+$405M
Cap. Flow %
14.45%
Top 10 Hldgs %
31.47%
Holding
745
New
93
Increased
296
Reduced
180
Closed
64

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$8.56M
2
CELG
Celgene Corp
CELG
+$6.53M
3
SNA icon
Snap-on
SNA
+$5.49M
4
AMG icon
Affiliated Managers Group
AMG
+$4.97M
5
MAR icon
Marriott International
MAR
+$3.57M

Sector Composition

Rank Sector Weight
1 Technology 18.14%
2 Healthcare 14.73%
3 Financials 11.88%
4 Consumer Discretionary 10.78%
5 Communication Services 8.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRUP icon
326
Trupanion
TRUP
$1.18B
$667K 0.02%
18,464
+8,277
+81% +$272K
GBT
327
DELISTED
Global Blood Therapeutics, Inc.
GBT
$661K 0.02%
12,563
-1,820
-13% -$105K
AEE icon
328
Ameren
AEE
$30.1B
$659K 0.02%
8,773
+1,962
+29% +$145K
ANSS
329
DELISTED
Ansys
ANSS
$659K 0.02%
3,218
+1,760
+121% +$335K
PAYC icon
330
Paycom
PAYC
$10B
$658K 0.02%
2,904
-4,463
-61% -$917K
PLAN
331
DELISTED
Anaplan, Inc.
PLAN
$650K 0.02%
12,873
+8,073
+168% +$334K
ZGNX
332
DELISTED
Zogenix, Inc.
ZGNX
$647K 0.02%
13,553
-306
-2% -$12.3K
ZBH icon
333
Zimmer Biomet
ZBH
$18.4B
$640K 0.02%
5,600
+234
+4% +$27.4K
TEAM icon
334
Atlassian
TEAM
$37.8B
$637K 0.02%
4,865
+3,696
+316% +$445K
DGX icon
335
Quest Diagnostics
DGX
$26.3B
$633K 0.02%
6,217
+1,638
+36% +$157K
TGT icon
336
Target
TGT
$68B
$631K 0.02%
+7,280
New +$588K
CAG icon
337
Conagra Brands
CAG
$7.23B
$628K 0.02%
23,675
ANET icon
338
Arista Networks
ANET
$238B
$627K 0.02%
38,640
+22,848
+145% +$395K
FND icon
339
Floor & Decor
FND
$6.68B
$627K 0.02%
14,948
-18,315
-55% -$765K
KRTX
340
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$627K 0.02%
+39,158
New +$784K
FISV
341
Fiserv Inc
FISV
$27.9B
$622K 0.02%
6,827
PRU icon
342
Prudential Financial
PRU
$41.8B
$616K 0.02%
6,101
+1,715
+39% +$171K
WAT icon
343
Waters Corp
WAT
$39.9B
$612K 0.02%
2,842
+933
+49% +$204K
BIIB icon
344
Biogen
BIIB
$30.7B
$610K 0.02%
2,609
+1,732
+197% +$400K
TRU icon
345
TransUnion
TRU
$15.3B
$610K 0.02%
8,293
+2,442
+42% +$167K
COLM icon
346
Columbia Sportswear
COLM
$2.93B
$603K 0.02%
+6,022
New +$597K
INSM icon
347
Insmed
INSM
$28.6B
$600K 0.02%
23,416
+18,433
+370% +$513K
ADM icon
348
Archer Daniels Midland
ADM
$36.9B
$590K 0.02%
14,456
-4,332
-23% -$179K
SEIC icon
349
SEI Investments
SEIC
$12.6B
$589K 0.02%
10,489
+2,558
+32% +$138K
RMD icon
350
ResMed
RMD
$30.7B
$587K 0.02%
4,807
-2,450
-34% -$271K

Similar funds

Tiverton Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Tiverton Asset Management held 745 positions worth $2.8B, up 22% from $2.31B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Tiverton Asset Management deployed $405M of net new capital in Q2 2019, opening 93 new positions and adding to 296 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 3,684,172 shares worth $145M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Celgene Corp, an estimated $6.53M trimmed.

  • Tiverton Asset Management's largest Q2 2019 buy was iShares Russell 1000 Growth ETF: 3,684,172 shares worth $145M.
  • Tiverton Asset Management added most to Air Products & Chemicals in Q2 2019, an estimated $12.7M increase.
  • Tiverton Asset Management's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $6.53M.
  • Tiverton Asset Management fully exited Linde in Q2 2019, selling an estimated $8.56M.
  • Tiverton Asset Management's ten largest holdings make up 31% of its $2.8B portfolio in Q2 2019.
  • Tiverton Asset Management opened 93 new positions and closed 64 in Q2 2019.
  • Tiverton Asset Management's portfolio value rose 22% quarter-over-quarter to $2.8B.

Based on Tiverton Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.